AzTrials
AzTrials

Developmental Language Disorder (DLD)DLD25!!NCT07426276

Evaluating the Effect of Combined Parent Training Plus Speech Therapy on Children With Speech Development Disorder.

A study testing Assisted speech therapy intervention + parent training and standard speech therapy in people with Developmental Language Disorder (DLD), run by IRCCS Centro Neurolesi Bonino Pulejo at 1 site in Italy.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Language is an extremely complex cognitive function that, in situations of typical development, i.e. in the absence of deficits or environmental risk, is generally acquired with apparent ease and naturalness (Kuhl, 2010). Read more about this study

Who is it for?
Ages 3 to 5 years
Conditions the study is for
Developmental Language Disorder (DLD)
What is being tested?
Assisted speech therapy intervention + parent training and standard speech therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteItaly
Study dates
10 Jan 2025to 25 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 5 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosis of 'Developmental Language Disorders' (DLD)
  • Age between 3 and 5 years.
  • Signature of informed consent by parents and/or legal guardians.

Who cannot join

  • No sensory impairment or another medical or neurological condition (ADHD, Autism, Deafness, Mental Retardation <70);
  • Significant medical conditions that could interfere with participation in the study.
  • Failure to sign informed consent by parents and/or legal guardians.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site
  • IRCCS Neurolesi Bonino Pulejo, Messina,, Messina, Messina 98124

    Messina, Messina, 98124

Other trials in Italy

About this study

Language is an extremely complex cognitive function that, in situations of typical development, i.e. in the absence of deficits or environmental risk, is generally acquired with apparent ease and naturalness (Kuhl, 2010).

The first 1,000 days of life are considered a key time window in which children's developmental trajectories and future outcomes are shaped. During this period, it is crucial to provide children with nurturing experiences such as responsive care and appropriate learning opportunities (Britto et al., 2017).

Read more

Most children learn communication skills (e.g., pointing, gesturing) and language skills (e.g., saying words, following instructions) from high-quality interactions with parents and caregivers. However, some children may have language learning difficulties for a variety of reasons, including genetic, neurological and environmental.

Not all children necessarily follow the stages outlined: some present delayed language development. The early identification and diagnosis of the language disorder is therefore very important as this deficit can have a negative impact on the child's subsequent development of skills, the way he/she relates and subsequent acquisition skills in primary school.

This research aims to assess whether parents, guided and monitored by the speech therapist and psychologist through parental training, can try out specific and effective strategies that enable them to become a facilitating model for the child's communicative-linguistic learning, thereby also improving their quality of life.

Being tested
Assisted speech therapy intervention + parent training, standard speech therapy
Medical subject headings
Language Development Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assisted speech therapy intervention + parent trainingBehavioural

    The intervention was tailored to individual needs and aimed at improving verbal expression, communicative initiative, and social engagement. Each child receives therapy for a period of 16 weeks, for a total of 32 sessions, twice a week, with each session lasting 45 minutes and in addition 16 sessions of parent traning once a week for 45 minutes.Intervention sessions included tasks designed to engage the child in verbal and social interactions, (such as naming objects, answering questions and performing gestures) to improve verbal expression communicative intention and social engagement, in parallel the parents once a week participate in a parent training session with the aim of supporting and directing them to learn strategies to improve interaction with the child and facilitate communicative-linguistic development

  • standard speech therapyBehavioural

    Therapy followed established protocols and was adapted to meet the specific needs of the children. Each child received therapy for a period of 16 weeks (twice a week), for a total of 32 sessions.• Standard therapeutic approaches included exercises to improve verbal communication and social engagement, such as object naming, sentence construction and comprehension tasks. Therapists adapted the intervention to the individual communication goals of each 45-minute session.

Study groups in NCT07426276
Study groupRoleWhat they receive
Assisted speech therapy intervention + parent trainingExperimentalThe treatment group consists of 20 children diagnosed with DLD (Language Development Disorder). The participants were randomly assigned and will undergo a structured rehabilitation programme of parent training + speech therapy
Receives: Behavioral: Assisted speech therapy intervention + parent training
Standard Speech TherapyActive comparatorThe control group consisted of 20 children diagnosed with DLD (Language Development Disorder). Participants were randomly assigned and were subjected to standard therapy approaches, which included traditional speech therapy provided by qualified therapists.
Receives: Behavioral: standard speech therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Language Development Level Test (TVL)

    The Test of Verbalization and Language Development is a standardized tool designed to assess various aspects of language development, including verbal production, comprehension, sentence construction, phonological accuracy, and morphosyntactic abilities. The weighted score ranges from 0 to 10, with higher scores indicating better language development.

    Measured: T0 (baseline)- T1 (6months)

  2. The Child Behavior Checklist (CBCL)

    The Child Behavior Checklist (CBCL) is a caregiver-reported questionnaire used to identify emotional and behavioral problems in children. It measures multiple domains, including emotional reactivity, anxiety, attention problems, and social difficulties. The T-scores do not have a specific range, but values between 50 and 70 are considered within the normal range, while 70 to 100 indicates clinical significance. Higher scores indicate greater behavioral problems.

    Measured: T0(baseline)-T1(6months)

  3. Questionnaire on Parenting Styles (QSP)

    This instrument consists of different forms that consider the three fundamental domains of parent-child interaction: a) the social domain: assessed through 8 items; b) the educational domain: assessed through 7 items; c) the disciplinary domain: assessed through 2 items. In this study, each parent completed four forms of the questionnaire: one assessing what their parental behaviour is like in reality (real style; Form A), one assessing what they would ideally like their own behaviour to be like (ideal style; Form B), one assessing what their partner's parental behaviour is like in reality (real style; Form C) and one assessing what they would ideally like their partner's parental behaviour to be like (ideal style; Form D).

    Measured: T0(baseline)-T1(6 months)

  4. WHOQOL

    It assesses individuals' perceptions of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, norms and standards.

    The WHOQOL-BRIEF is a 26-item self-report instrument that assesses four domains that are assumed to represent the Quality of Life (QOL) construct: the physical domain, the psychological domain, the social relations domain and the environmental domain, plus two aspects for assessing overall QOL and general health.

    It provides a multi-dimensional profile of QOL domain and sub-domain scores

    Measured: T0(baseline)-T1(6 months)

  5. Il Parenting Stress Index

    It defines the level of stress (anxiety, discomfort, maladaptive coping, etc.) that a parent is experiencing in their parental role.

    It is closely linked to personal characteristics of the subject that reverberate in the way he or she performs and experiences this role.

    The stress components most associated with this subscale are:

    a negative experience regarding one's parental competence; stress resulting from the restrictions the parental role places on other social roles important to the subject; conflict with the spouse; lack of social support; and the presence of depression in the clinical sense.

    Measured: T0(baseline)-T1(6 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2026
  2. Study start10 Jan 2025
  3. Primary completion25 Jun 2026 (estimated)
  4. Study completion25 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07426276
Sponsor's protocol ID
DLD25
Acronym
DLD25!!
Status last verified
Feb 2026
First submitted
16 Feb 2026
Last updated
23 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Zwitserlood-Nijenhuis MA, Wiefferink CH, Gerrits E. A randomized study of parent- versus child-directed intervention for Dutch toddlers with DLD. Int J Lang Commun Disord. 2023 Sep-Oct;58(5):1768-1782. doi: 10.1111/1460-6984.12901. Epub 2023 May 29.

    PubMed 37248804
  • Hawa VV, Spanoudis G. Toddlers with delayed expressive language: an overview of the characteristics, risk factors and language outcomes. Res Dev Disabil. 2014 Feb;35(2):400-7. doi: 10.1016/j.ridd.2013.10.027. Epub 2013 Dec 14.

    PubMed 24334229
  • Collisson BA, Graham SA, Preston JL, Rose MS, McDonald S, Tough S. Risk and Protective Factors for Late Talking: An Epidemiologic Investigation. J Pediatr. 2016 May;172:168-174.e1. doi: 10.1016/j.jpeds.2016.02.020. Epub 2016 Mar 8.

    PubMed 26968834
  • Rowe ML. A longitudinal investigation of the role of quantity and quality of child-directed speech in vocabulary development. Child Dev. 2012 Sep-Oct;83(5):1762-74. doi: 10.1111/j.1467-8624.2012.01805.x. Epub 2012 Jun 20.

    PubMed 22716950
  • Buschmann A, Jooss B, Rupp A, Dockter S, Blaschtikowitz H, Heggen I, Pietz J. Children with developmental language delay at 24 months of age: results of a diagnostic work-up. Dev Med Child Neurol. 2008 Mar;50(3):223-9. doi: 10.1111/j.1469-8749.2008.02034.x. Epub 2008 Feb 11.

    PubMed 18266869
  • Britto PR, Lye SJ, Proulx K, Yousafzai AK, Matthews SG, Vaivada T, Perez-Escamilla R, Rao N, Ip P, Fernald LCH, MacMillan H, Hanson M, Wachs TD, Yao H, Yoshikawa H, Cerezo A, Leckman JF, Bhutta ZA; Early Childhood Development Interventions Review Group, for the Lancet Early Childhood Development Series Steering Committee. Nurturing care: promoting early childhood development. Lancet. 2017 Jan 7;389(10064):91-102. doi: 10.1016/S0140-6736(16)31390-3. Epub 2016 Oct 4.

    PubMed 27717615

Questions about this trial

What is this clinical trial studying?

A study testing Assisted speech therapy intervention + parent training and standard speech therapy in people with Developmental Language Disorder (DLD), run by IRCCS Centro Neurolesi Bonino Pulejo at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 23 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Language Development Level Test (TVL) (time frame: T0 (baseline)- T1 (6months)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07426276, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in